$XXII
22nd Century Group, Inc.

2021 Q4 Form 10-Q Financial Statement

#000155837021014427 Filed on November 04, 2021

View on sec.gov

Income Statement

Concept 2021 Q4 2021 Q3 2020 Q4
Revenue $7.960M $7.811M $7.308M
YoY Change 8.92% 6.85% 0.63%
Cost Of Revenue $7.573M $7.362M $6.720M
YoY Change 12.69% 5.96% -4.51%
Gross Profit $387.0K $449.0K $588.0K
YoY Change -34.18% 24.03% 161.65%
Gross Profit Margin 4.86% 5.75% 8.05%
Selling, General & Admin $8.054M $6.821M $5.162M
YoY Change 56.02% 115.24% 34.52%
% of Gross Profit 2081.14% 1519.15% 877.89%
Research & Development $971.0K $856.0K $1.410M
YoY Change -31.13% -5.93% -13.31%
% of Gross Profit 250.9% 190.65% 239.8%
Depreciation & Amortization $316.0K $173.0K $348.0K
YoY Change -9.2% 8.13% 10.85%
% of Gross Profit 81.65% 38.53% 59.18%
Operating Expenses $9.341M $8.018M $6.805M
YoY Change 37.27% 82.14% 17.78%
Operating Profit -$8.954M -$7.569M -$6.248M
YoY Change 43.31% 87.35% 12.54%
Interest Expense -$4.919M $23.00K $394.0K
YoY Change -1348.48% 0.0% -161.04%
% of Operating Profit
Other Income/Expense, Net -$1.871M $128.0K
YoY Change 933.7% -112.67%
Pretax Income -$13.95M -$9.440M -$6.404M
YoY Change 117.85% 123.64% 3.32%
Income Tax $14.00K $0.00 $0.00
% Of Pretax Income
Net Earnings -$13.97M -$9.440M -$6.405M
YoY Change 118.03% 123.64% 3.34%
Net Earnings / Revenue -175.44% -120.86% -87.64%
Basic Earnings Per Share -$0.03 -$0.06
Diluted Earnings Per Share -$85.76K -$58.01K -$46.10K
COMMON SHARES
Basic Shares Outstanding 162.7M 162.7M 138.9M
Diluted Shares Outstanding 162.7M

Balance Sheet

Concept 2021 Q4 2021 Q3 2020 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $48.74M $55.16M $22.34M
YoY Change 118.14% 105.69% -42.66%
Cash & Equivalents $1.336M $1.629M $1.029M
Short-Term Investments $47.40M $53.53M $21.31M
Other Short-Term Assets $2.183M $3.131M $1.806M
YoY Change 20.87% 30.4% 178.64%
Inventory $2.881M $2.703M $2.034M
Prepaid Expenses
Receivables $585.0K $1.179M $2.159M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $54.39M $62.17M $28.34M
YoY Change 91.9% 87.9% -33.69%
LONG-TERM ASSETS
Property, Plant & Equipment $5.841M $4.754M $2.483M
YoY Change 135.24% 45.78% -33.29%
Goodwill $0.00
YoY Change
Intangibles $7.919M $8.036M $8.211M
YoY Change -3.56% -2.37% -3.33%
Long-Term Investments $2.345M $7.300M $6.536M
YoY Change -64.12% 4.06% -22.21%
Other Assets $3.741M $3.713M $5.876M
YoY Change -36.33%
Total Long-Term Assets $21.57M $24.28M $23.35M
YoY Change -7.64% -0.12% -10.89%
TOTAL ASSETS
Total Short-Term Assets $54.39M $62.17M $28.34M
Total Long-Term Assets $21.57M $24.28M $23.35M
Total Assets $75.95M $86.46M $51.69M
YoY Change 46.93% 50.62% -25.03%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $2.173M $1.443M $1.116M
YoY Change 94.71% 29.53% -44.12%
Accrued Expenses $1.489M $3.440M $931.0K
YoY Change 59.94% 9.38% -64.45%
Deferred Revenue $119.0K $0.00 $272.0K
YoY Change -56.25% 5340.0%
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $596.0K $1.782M $539.0K
YoY Change 10.58% 17.01% -7.18%
Total Short-Term Liabilities $8.427M $6.962M $7.343M
YoY Change 14.76% 6.39% 27.02%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change -100.0% -100.0%
Other Long-Term Liabilities $21.00K $479.0K $241.0K
YoY Change -91.29% -9.11% -70.89%
Total Long-Term Liabilities $21.00K $479.0K $241.0K
YoY Change -91.29% -41.51% -78.48%
TOTAL LIABILITIES
Total Short-Term Liabilities $8.427M $6.962M $7.343M
Total Long-Term Liabilities $21.00K $479.0K $241.0K
Total Liabilities $9.880M $7.441M $7.584M
YoY Change 30.27% 1.06% 9.9%
SHAREHOLDERS EQUITY
Retained Earnings -$178.0M -$164.0M -$145.4M
YoY Change 22.43% 18.02% 15.68%
Common Stock $2.000K $2.000K $1.000K
YoY Change 100.0% 100.0% 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $66.07M $79.01M $44.11M
YoY Change
Total Liabilities & Shareholders Equity $75.95M $86.46M $51.69M
YoY Change 46.93% 50.62% -25.03%

Cashflow Statement

Concept 2021 Q4 2021 Q3 2020 Q4
OPERATING ACTIVITIES
Net Income -$13.97M -$9.440M -$6.405M
YoY Change 118.03% 123.64% 3.34%
Depreciation, Depletion And Amortization $316.0K $173.0K $348.0K
YoY Change -9.2% 8.13% 10.85%
Cash From Operating Activities -$4.632M -$5.937M -$2.997M
YoY Change 54.55% 415.81% 3.71%
INVESTING ACTIVITIES
Capital Expenditures -$362.0K -$142.0K -$147.0K
YoY Change 146.26% 5.19% 20.65%
Acquisitions
YoY Change
Other Investing Activities $5.840M $6.602M $3.861M
YoY Change 51.26% 143.53% -151.92%
Cash From Investing Activities $5.478M $6.460M $3.714M
YoY Change 47.5% 150.78% -149.14%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -1.139M -931.0K -1.230M
YoY Change -7.4% 28.06% -111.92%
NET CHANGE
Cash From Operating Activities -4.632M -5.937M -2.997M
Cash From Investing Activities 5.478M 6.460M 3.714M
Cash From Financing Activities -1.139M -931.0K -1.230M
Net Change In Cash -293.0K -408.0K -513.0K
YoY Change -42.88% -158.45% 286.67%
FREE CASH FLOW
Cash From Operating Activities -$4.632M -$5.937M -$2.997M
Capital Expenditures -$362.0K -$142.0K -$147.0K
Free Cash Flow -$4.270M -$5.795M -$2.850M
YoY Change 49.82% 470.37% 2.96%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2021Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2020Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
dei Entity Central Index Key
EntityCentralIndexKey
0001347858
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2021
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Amendment Flag
AmendmentFlag
false
CY2021Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
162735483
CY2020Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
139061690
CY2019 xxii Postemployment Benefit Period
PostemploymentBenefitPeriod
P42M
CY2021Q2 xxii Directors And Officers Insurance Policy Term
DirectorsAndOfficersInsurancePolicyTerm
P1Y
CY2021Q2 us-gaap Debt Instrument Term
DebtInstrumentTerm
P9M
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2021-09-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-36338
dei Entity Registrant Name
EntityRegistrantName
22nd Century Group, Inc.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
NV
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
98-0468420
dei Entity Address Address Line1
EntityAddressAddressLine1
500 Seneca Street
dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 507
dei Entity Address City Or Town
EntityAddressCityOrTown
Buffalo
dei Entity Address State Or Province
EntityAddressStateOrProvince
NY
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
14204
dei City Area Code
CityAreaCode
716
dei Local Phone Number
LocalPhoneNumber
270-1523
dei Security12b Title
Security12bTitle
Common Stock, $0.00001 par value
dei Trading Symbol
TradingSymbol
XXII
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2021Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
162748483
CY2021Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1629000
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1029000
CY2021Q3 us-gaap Short Term Investments
ShortTermInvestments
53532000
CY2020Q4 us-gaap Short Term Investments
ShortTermInvestments
21313000
CY2021Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
1179000
CY2020Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
2159000
CY2021Q3 us-gaap Inventory Net
InventoryNet
2703000
CY2020Q4 us-gaap Inventory Net
InventoryNet
2034000
CY2021Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
3131000
CY2020Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1806000
CY2021Q3 us-gaap Assets Current
AssetsCurrent
62174000
CY2020Q4 us-gaap Assets Current
AssetsCurrent
28341000
CY2021Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
4754000
CY2020Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2483000
CY2021Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
478000
CY2020Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
247000
CY2021Q3 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
8036000
CY2020Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
8211000
CY2021Q3 us-gaap Long Term Investments
LongTermInvestments
7300000
CY2020Q4 us-gaap Long Term Investments
LongTermInvestments
6536000
CY2021Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
3713000
CY2020Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
5876000
CY2021Q3 us-gaap Assets
Assets
86455000
CY2020Q4 us-gaap Assets
Assets
51694000
CY2021Q3 us-gaap Notes Payable Current
NotesPayableCurrent
1782000
CY2020Q4 us-gaap Notes Payable Current
NotesPayableCurrent
539000
CY2021Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
74000
CY2020Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
247000
CY2021Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
1443000
CY2020Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
1116000
CY2021Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
3440000
CY2020Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
4830000
CY2021Q3 us-gaap Postemployment Benefits Liability Current
PostemploymentBenefitsLiabilityCurrent
223000
CY2020Q4 us-gaap Postemployment Benefits Liability Current
PostemploymentBenefitsLiabilityCurrent
339000
CY2021Q3 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
0
CY2020Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
272000
CY2021Q3 us-gaap Liabilities Current
LiabilitiesCurrent
6962000
CY2020Q4 us-gaap Liabilities Current
LiabilitiesCurrent
7343000
CY2021Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
407000
CY2020Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
0
CY2021Q3 us-gaap Postemployment Benefits Liability Noncurrent
PostemploymentBenefitsLiabilityNoncurrent
72000
CY2020Q4 us-gaap Postemployment Benefits Liability Noncurrent
PostemploymentBenefitsLiabilityNoncurrent
241000
CY2021Q3 us-gaap Liabilities
Liabilities
7441000
CY2020Q4 us-gaap Liabilities
Liabilities
7584000
CY2021Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2020Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2021Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.00001
CY2020Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.00001
CY2021Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
300000000
CY2020Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
300000000
CY2021Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.00001
CY2020Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.00001
CY2021Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
162735483
CY2020Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
139061690
CY2021Q3 us-gaap Common Stock Value
CommonStockValue
2000
CY2020Q4 us-gaap Common Stock Value
CommonStockValue
1000
CY2021Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
243087000
CY2020Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
189439000
CY2021Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-27000
CY2020Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
74000
CY2021Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-164048000
CY2020Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-145404000
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
79014000
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
44110000
CY2021Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
86455000
CY2020Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
51694000
CY2021Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
7811000
CY2020Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
7310000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
22988000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
20803000
CY2021Q3 us-gaap Cost Of Goods And Service Excluding Depreciation Depletion And Amortization
CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization
7362000
CY2020Q3 us-gaap Cost Of Goods And Service Excluding Depreciation Depletion And Amortization
CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization
6948000
us-gaap Cost Of Goods And Service Excluding Depreciation Depletion And Amortization
CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization
21306000
us-gaap Cost Of Goods And Service Excluding Depreciation Depletion And Amortization
CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization
19953000
CY2021Q3 xxii Gross Profit Excluding Depreciation
GrossProfitExcludingDepreciation
449000
CY2020Q3 xxii Gross Profit Excluding Depreciation
GrossProfitExcludingDepreciation
362000
xxii Gross Profit Excluding Depreciation
GrossProfitExcludingDepreciation
1682000
xxii Gross Profit Excluding Depreciation
GrossProfitExcludingDepreciation
850000
CY2021Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
6821000
CY2020Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
3169000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
17827000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
9809000
us-gaap Impairment Of Intangible Assets Excluding Goodwill
ImpairmentOfIntangibleAssetsExcludingGoodwill
146000
CY2021Q3 us-gaap Depreciation
Depreciation
173000
CY2020Q3 us-gaap Depreciation
Depreciation
160000
us-gaap Depreciation
Depreciation
461000
us-gaap Depreciation
Depreciation
473000
CY2021Q3 us-gaap Adjustment For Amortization
AdjustmentForAmortization
168000
CY2020Q3 us-gaap Adjustment For Amortization
AdjustmentForAmortization
163000
us-gaap Adjustment For Amortization
AdjustmentForAmortization
471000
us-gaap Adjustment For Amortization
AdjustmentForAmortization
524000
CY2021Q3 us-gaap Operating Expenses
OperatingExpenses
8018000
CY2020Q3 us-gaap Operating Expenses
OperatingExpenses
4402000
us-gaap Operating Expenses
OperatingExpenses
21062000
us-gaap Operating Expenses
OperatingExpenses
13786000
CY2021Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-7569000
CY2020Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-4040000
us-gaap Operating Income Loss
OperatingIncomeLoss
-19380000
us-gaap Operating Income Loss
OperatingIncomeLoss
-12936000
CY2021Q3 us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
-1900000
CY2020Q3 us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
-429000
us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
-2040000
us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
-562000
us-gaap Equity Securities Without Readily Determinable Fair Value Impairment Loss Annual Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount
1062000
xxii Debt Securities Realized Gain Loss On Conversion
DebtSecuritiesRealizedGainLossOnConversion
2548000
CY2021Q3 us-gaap Investment Income Net
InvestmentIncomeNet
52000
CY2020Q3 us-gaap Investment Income Net
InvestmentIncomeNet
270000
us-gaap Investment Income Net
InvestmentIncomeNet
272000
us-gaap Investment Income Net
InvestmentIncomeNet
1344000
CY2021Q3 us-gaap Interest Expense
InterestExpense
23000
CY2020Q3 us-gaap Interest Expense
InterestExpense
23000
us-gaap Interest Expense
InterestExpense
44000
us-gaap Interest Expense
InterestExpense
54000
CY2021Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-1871000
CY2020Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-181000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
736000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-333000
CY2021Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-9440000
CY2020Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-4221000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-18644000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-13269000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
38000
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-9440000
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
-4221000
us-gaap Net Income Loss
NetIncomeLoss
-18644000
us-gaap Net Income Loss
NetIncomeLoss
-13307000
CY2021Q3 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-28000
CY2020Q3 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
87000
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-101000
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
132000
CY2021Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-28000
CY2020Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
87000
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-101000
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
132000
CY2021Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-9468000
CY2020Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-4134000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-18745000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-13175000
CY2021Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.06
CY2020Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.03
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.12
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.10
CY2021Q3 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
162721000
CY2020Q3 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
138857000
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
153998000
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
138774000
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
44110000
CY2021Q1 us-gaap Stock Issued During Period Value Restricted Stock Award Gross
StockIssuedDuringPeriodValueRestrictedStockAwardGross
0
CY2021Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
1153000
CY2021Q1 xxii Stock Issued During Period Value Warrants Exercise
StockIssuedDuringPeriodValueWarrantsExercise
11782000
CY2021Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
507000
CY2021Q1 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Before Reclassification Adjustments Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsNetOfTax
-32000
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
-5030000
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
52490000
CY2021Q2 xxii Stock Issued During Period Value Restricted Stock Award Net Of Shares Withheld For Taxes
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfSharesWithheldForTaxes
-469000
CY2021Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
106000
CY2021Q2 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
38206000
CY2021Q2 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
1245000
CY2021Q2 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Before Reclassification Adjustments Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsNetOfTax
-41000
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-4174000
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
87363000
CY2021Q3 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
1119000
CY2021Q3 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Before Reclassification Adjustments Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsNetOfTax
-28000
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-9440000
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
79014000
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
62050000
CY2020Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
480000
CY2020Q1 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Before Reclassification Adjustments Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsNetOfTax
-196000
CY2020Q1 us-gaap Other Comprehensive Income Loss Before Reclassifications Net Of Tax
OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
3000
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
-4029000
CY2020Q1 us-gaap Stockholders Equity
StockholdersEquity
58308000
CY2020Q2 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
376000
CY2020Q2 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Before Reclassification Adjustments Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsNetOfTax
241000
CY2020Q2 us-gaap Other Comprehensive Income Loss Before Reclassifications Net Of Tax
OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
-3000
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
-5057000
CY2020Q2 us-gaap Stockholders Equity
StockholdersEquity
53865000
CY2020Q3 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
306000
CY2020Q3 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Before Reclassification Adjustments Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsNetOfTax
87000
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
-4221000
CY2020Q3 us-gaap Stockholders Equity
StockholdersEquity
50037000
us-gaap Profit Loss
ProfitLoss
-18644000
us-gaap Profit Loss
ProfitLoss
-13307000
us-gaap Impairment Of Intangible Assets Excluding Goodwill
ImpairmentOfIntangibleAssetsExcludingGoodwill
146000
us-gaap Equity Securities Without Readily Determinable Fair Value Impairment Loss Annual Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount
1062000
xxii Amortization And Depreciation Excluding Amortization Of Intangibles
AmortizationAndDepreciationExcludingAmortizationOfIntangibles
745000
xxii Amortization And Depreciation Excluding Amortization Of Intangibles
AmortizationAndDepreciationExcludingAmortizationOfIntangibles
810000
xxii Amortization Of License Fees
AmortizationOfLicenseFees
187000
xxii Amortization Of License Fees
AmortizationOfLicenseFees
187000
us-gaap Operating Lease Cost
OperatingLeaseCost
214000
us-gaap Operating Lease Cost
OperatingLeaseCost
232000
us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
-2040000
us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
-562000
xxii Gain Loss On Sale Of Property Plant And Equipment Nonoperating
GainLossOnSaleOfPropertyPlantAndEquipmentNonoperating
1000
xxii Debt Securities Realized Gain Loss On Conversion
DebtSecuritiesRealizedGainLossOnConversion
2548000
xxii Accretion Income
AccretionIncome
-13000
xxii Accretion Income
AccretionIncome
222000
us-gaap Share Based Compensation
ShareBasedCompensation
2871000
us-gaap Share Based Compensation
ShareBasedCompensation
1162000
us-gaap Inventory Write Down
InventoryWriteDown
219000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-980000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
692000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
669000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
264000
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
1494000
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
1754000
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-212000
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-228000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
289000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-924000
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-1422000
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
481000
us-gaap Increase Decrease In Deferred Compensation
IncreaseDecreaseInDeferredCompensation
-285000
us-gaap Increase Decrease In Deferred Compensation
IncreaseDecreaseInDeferredCompensation
-88000
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-272000
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-5000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-18207000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-12624000
us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
239000
us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
342000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
470000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
33000
us-gaap Proceeds From Sale And Maturity Of Trading Securities Heldforinvestment
ProceedsFromSaleAndMaturityOfTradingSecuritiesHeldforinvestment
52203000
us-gaap Proceeds From Sale And Maturity Of Trading Securities Heldforinvestment
ProceedsFromSaleAndMaturityOfTradingSecuritiesHeldforinvestment
28960000
us-gaap Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
84701000
us-gaap Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
15830000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-33207000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
12755000
us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
1417000
us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
1269000
us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
2653000
us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
2195000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
1259000
us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
11782000
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
38206000
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
469000
us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
1183000
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
1183000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
52014000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
926000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
600000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
1057000
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1029000
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
485000
CY2021Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1629000
CY2020Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1542000
us-gaap Interest Paid Net
InterestPaidNet
26000
us-gaap Interest Paid Net
InterestPaidNet
19000
xxii Patent And Trademark Additions Included In Accounts Payable
PatentAndTrademarkAdditionsIncludedInAccountsPayable
35000
xxii Patent And Trademark Additions Included In Accounts Payable
PatentAndTrademarkAdditionsIncludedInAccountsPayable
19000
xxii Property Plant And Equipment Additions Included In Accounts Payable
PropertyPlantAndEquipmentAdditionsIncludedInAccountsPayable
4000
xxii Property Plant And Equipment Additions Included In Accounts Payable
PropertyPlantAndEquipmentAdditionsIncludedInAccountsPayable
9000
xxii Property Plant And Equipment Additions Included In Accrued Expenses
PropertyPlantAndEquipmentAdditionsIncludedInAccruedExpenses
10000
xxii Right Of Use Assets And Corresponding Operating Lease Obligations
RightOfUseAssetsAndCorrespondingOperatingLeaseObligations
497000
xxii Right Of Use Assets And Corresponding Operating Lease Obligations
RightOfUseAssetsAndCorrespondingOperatingLeaseObligations
198000
xxii Patent And Trademark Additions Included In Accrued Liabilities Current
PatentAndTrademarkAdditionsIncludedInAccruedLiabilitiesCurrent
22000
xxii Patent And Trademark Additions Included In Accrued Liabilities Current
PatentAndTrademarkAdditionsIncludedInAccruedLiabilitiesCurrent
46000
xxii Noncash Investment Conversion
NoncashInvestmentConversion
12485000
xxii Number Of Subsidiaries
NumberOfSubsidiaries
4
us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">Reclassifications </span><i style="font-style:italic;">–</i> Certain prior period amounts have been reclassified to conform to the current period’s classification. None of these reclassifications had a material impact on our consolidated financial statements.</p>
us-gaap Use Of Estimates
UseOfEstimates
<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">Use of Estimates</span><i style="font-style:italic;"> </i><b style="font-weight:bold;">-</b><i style="font-style:italic;"> </i>The preparation of financial statements in conformity with accounting principles generally accepted in the U.S. requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of income and expenses during the reporting period. Actual results could differ from those estimates.</p>
us-gaap Inventory Write Down
InventoryWriteDown
219000
CY2021Q3 xxii Inventory Tobacco Leaf Gross
InventoryTobaccoLeafGross
876000
CY2020Q4 xxii Inventory Tobacco Leaf Gross
InventoryTobaccoLeafGross
821000
CY2021Q3 xxii Inventory Hemp Cannabis Gross
InventoryHempCannabisGross
132000
CY2021Q3 us-gaap Inventory Finished Goods
InventoryFinishedGoods
331000
CY2020Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
171000
CY2021Q3 xxii Inventory Raw Materials Excluding Tobacco Leaf
InventoryRawMaterialsExcludingTobaccoLeaf
1464000
CY2020Q4 xxii Inventory Raw Materials Excluding Tobacco Leaf
InventoryRawMaterialsExcludingTobaccoLeaf
1142000
CY2021Q3 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
100000
CY2020Q4 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
100000
CY2021Q3 us-gaap Inventory Net
InventoryNet
2703000
CY2020Q4 us-gaap Inventory Net
InventoryNet
2034000
CY2021Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
3128000
CY2020Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
2670000
CY2021Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
4754000
CY2020Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2483000
CY2021Q3 us-gaap Depreciation
Depreciation
173000
us-gaap Depreciation
Depreciation
461000
CY2020Q3 us-gaap Depreciation
Depreciation
160000
us-gaap Depreciation
Depreciation
473000
CY2021Q3 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P6Y3M18D
CY2021Q3 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.037
CY2021Q3 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
33000
CY2021Q3 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
76000
CY2021Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
78000
CY2021Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
80000
CY2021Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
82000
CY2021Q3 us-gaap Lessee Operating Lease Liability Payments Due After Year Five
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
192000
CY2021Q3 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
541000
CY2021Q3 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
60000
CY2021Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
481000
CY2021Q3 us-gaap Long Term Investments
LongTermInvestments
7300000
CY2020Q4 us-gaap Long Term Investments
LongTermInvestments
6536000
CY2020Q4 us-gaap Notes Receivable Related Parties Noncurrent
NotesReceivableRelatedPartiesNoncurrent
5876000
CY2021Q3 us-gaap Notes Receivable Related Parties Noncurrent
NotesReceivableRelatedPartiesNoncurrent
3713000
CY2020Q4 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Value
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue
11288000
us-gaap Fair Value Assets Measured On Recurring Basis Change In Unrealized Gain Loss
FairValueAssetsMeasuredOnRecurringBasisChangeInUnrealizedGainLoss
-220000
xxii Accreted Interest Income On Convertible Note Receivable
AccretedInterestIncomeOnConvertibleNoteReceivable
142000
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Settlements
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements
11192000
CY2021Q3 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Value
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue
18000
CY2020Q4 us-gaap Debt Securities Available For Sale Amortized Cost After Allowance For Credit Loss
DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss
23652000
CY2020Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
74000
CY2020Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
0
CY2020Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
23726000
CY2021Q3 us-gaap Available For Sale Securities Debt Maturities Within One Year Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost
3581000
CY2021Q3 us-gaap Available For Sale Securities Debt Maturities Within One Year Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
3585000
CY2020Q4 us-gaap Available For Sale Securities Debt Maturities Within One Year Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost
11692000
CY2020Q4 us-gaap Available For Sale Securities Debt Maturities Within One Year Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
11753000
CY2021Q3 us-gaap Available For Sale Securities Debt Maturities After One Through Five Years Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost
31497000
CY2021Q3 us-gaap Available For Sale Securities Debt Maturities After One Through Five Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue
31466000
CY2020Q4 us-gaap Available For Sale Securities Debt Maturities After One Through Five Years Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost
11960000
CY2020Q4 us-gaap Available For Sale Securities Debt Maturities After One Through Five Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue
11973000
CY2021Q3 us-gaap Debt Securities Available For Sale Amortized Cost After Allowance For Credit Loss
DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss
35078000
CY2021Q3 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
35051000
CY2020Q4 us-gaap Debt Securities Available For Sale Amortized Cost After Allowance For Credit Loss
DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss
23652000
CY2020Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
23726000
CY2021Q3 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
8036000
CY2020Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
8211000
CY2021Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
168000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
471000
CY2020Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
163000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
524000
CY2021Q3 us-gaap Impairment Of Intangible Assets Excluding Goodwill
ImpairmentOfIntangibleAssetsExcludingGoodwill
0
us-gaap Impairment Of Intangible Assets Excluding Goodwill
ImpairmentOfIntangibleAssetsExcludingGoodwill
146000
xxii Finite Lived Intangible Assets Written Off Due To Impairment Cost
FiniteLivedIntangibleAssetsWrittenOffDueToImpairmentCost
448000
xxii Finite Lived Intangible Assets Written Off Due To Impairment Accumulated Amortization
FiniteLivedIntangibleAssetsWrittenOffDueToImpairmentAccumulatedAmortization
302000
CY2021Q2 xxii Directors And Officers Insurance Premium
DirectorsAndOfficersInsurancePremium
3315000
CY2021Q2 xxii Directors And Officers Insurance Premium Paid
DirectorsAndOfficersInsurancePremiumPaid
662000
CY2021Q2 us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
2653000
CY2021Q2 us-gaap Debt Instrument Interest Rate Stated Percentage
DebtInstrumentInterestRateStatedPercentage
0.0349
CY2020Q2 xxii Directors And Officers Insurance Policy Term
DirectorsAndOfficersInsurancePolicyTerm
P1Y
CY2020Q2 xxii Directors And Officers Insurance Premium
DirectorsAndOfficersInsurancePremium
2744000
CY2020Q2 xxii Directors And Officers Insurance Premium Paid
DirectorsAndOfficersInsurancePremiumPaid
549000
CY2020Q2 us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
2195000
CY2020Q2 us-gaap Debt Instrument Term
DebtInstrumentTerm
P9M
CY2020Q2 us-gaap Debt Instrument Interest Rate Stated Percentage
DebtInstrumentInterestRateStatedPercentage
0.0319
CY2020Q2 us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
1200000
CY2021Q3 xxii License Fees Payable Current
LicenseFeesPayableCurrent
299000
CY2020Q4 xxii License Fees Payable Current
LicenseFeesPayableCurrent
293000
CY2021Q3 xxii Directors And Officers Insurance Payable Current
DirectorsAndOfficersInsurancePayableCurrent
1483000
CY2020Q4 xxii Directors And Officers Insurance Payable Current
DirectorsAndOfficersInsurancePayableCurrent
246000
CY2021Q3 us-gaap Notes Payable Current
NotesPayableCurrent
1782000
CY2020Q4 us-gaap Notes Payable Current
NotesPayableCurrent
539000
CY2020Q2 us-gaap Postemployment Benefits Period Expense
PostemploymentBenefitsPeriodExpense
306000
CY2019 us-gaap Postemployment Benefits Period Expense
PostemploymentBenefitsPeriodExpense
881000
CY2019Q4 us-gaap Supplemental Unemployment Benefits Severance Benefits
SupplementalUnemploymentBenefitsSeveranceBenefits
771000
CY2021Q3 us-gaap Postemployment Benefits Liability Current
PostemploymentBenefitsLiabilityCurrent
223000
CY2021Q3 us-gaap Postemployment Benefits Liability Noncurrent
PostemploymentBenefitsLiabilityNoncurrent
72000
CY2020Q4 us-gaap Postemployment Benefits Liability Current
PostemploymentBenefitsLiabilityCurrent
339000
CY2020Q4 us-gaap Postemployment Benefits Liability Noncurrent
PostemploymentBenefitsLiabilityNoncurrent
241000
CY2021Q2 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
10000000
CY2021Q2 us-gaap Share Price
SharePrice
4.00
CY2021Q2 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
38206000
CY2021Q1 xxii Number Of Warrants Exercised
NumberOfWarrantsExercised
11293211
CY2021Q1 us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
11782000
CY2020Q4 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
11293211
CY2021Q1 xxii Number Of Warrants Exercised
NumberOfWarrantsExercised
11293211
CY2021Q3 us-gaap Contractual Obligation Future Minimum Payments Due Remainder Of Fiscal Year
ContractualObligationFutureMinimumPaymentsDueRemainderOfFiscalYear
511000
CY2021Q3 us-gaap Contractual Obligation Due In Next Twelve Months
ContractualObligationDueInNextTwelveMonths
1859000
CY2021Q3 us-gaap Contractual Obligation Due In Second Year
ContractualObligationDueInSecondYear
1310000
CY2021Q3 us-gaap Contractual Obligation Due In Third Year
ContractualObligationDueInThirdYear
1337000
CY2021Q3 xxii Contractual Obligation Due After Fourth Year
ContractualObligationDueAfterFourthYear
4103000
CY2021Q3 us-gaap Contractual Obligation
ContractualObligation
9120000
CY2019Q4 us-gaap Loss Contingency Pending Claims Number
LossContingencyPendingClaimsNumber
3
CY2020Q1 us-gaap Loss Contingency Pending Claims Number
LossContingencyPendingClaimsNumber
3
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Additional Shares Authorized
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized
5000000
xxii Share Based Compensation Arrangement Plan Term
ShareBasedCompensationArrangementPlanTerm
P10Y
CY2021Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
7449946
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
2938000
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
0.85
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
1995000
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
3.20
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
1234000
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
0.85
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
216000
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
0.67
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
3483000
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
2.21
CY2021Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
15000
CY2021Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
4.60
CY2021Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
288000
CY2021Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
0.86
CY2021Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
25000
CY2021Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
1.04
CY2021Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
3185000
CY2021Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
2.35
CY2021Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
190000
CY2021Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
3.71
CY2021Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
50000
CY2021Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
0.80
CY2021Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
10000
CY2021Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
1.90
CY2021Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
3315000
CY2021Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
2.45
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Total Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue
5057000
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
6581000
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
1.50
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
235000
CY2021Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
3.10
CY2021Q1 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
846000
CY2021Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
1.36
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
6000
CY2021Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
2.76
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
5964000
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
1.59
CY2021Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P4Y3M18D
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
7480000
CY2021Q2 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
88000
CY2021Q2 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
1.21
CY2021Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
100000
CY2021Q2 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
0.80
CY2021Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
5776000
CY2021Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
1.60
CY2021Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P4Y1M6D
CY2021Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
13265000
CY2021Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
40000
CY2021Q3 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
2.58
CY2021Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
500000
CY2021Q3 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
1.04
CY2021Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
5236000
CY2021Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
1.65
CY2021Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P3Y9M18D
CY2021Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
6885000
CY2021Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
4900000
CY2021Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
1.56
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P3Y8M12D
CY2021Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
6848000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0054
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.8792
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P4Y1M2D
CY2021Q3 us-gaap Share Based Compensation
ShareBasedCompensation
1119000
CY2020Q3 us-gaap Share Based Compensation
ShareBasedCompensation
306000
us-gaap Share Based Compensation
ShareBasedCompensation
2871000
us-gaap Share Based Compensation
ShareBasedCompensation
1162000
CY2021Q3 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
5931000
us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P1Y1M6D
CY2021Q3 xxii Employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedstockoptionswithmilestonebasedvesting
Employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedstockoptionswithmilestonebasedvesting
517000
CY2021Q3 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
0
CY2020Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
0
xxii Contract Asset Payment Period After Shipment
ContractAssetPaymentPeriodAfterShipment
P21D
CY2021Q3 us-gaap Contract With Customer Asset Net Current
ContractWithCustomerAssetNetCurrent
494000
CY2020Q4 us-gaap Contract With Customer Asset Net Current
ContractWithCustomerAssetNetCurrent
349000
CY2020Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
272000
CY2021Q3 xxii Contract Asset Liability Net
ContractAssetLiabilityNet
494000
CY2020Q4 xxii Contract Asset Liability Net
ContractAssetLiabilityNet
77000
CY2021Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
7811000
CY2020Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
7310000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
22988000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
20803000
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-9440000
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
-4221000
us-gaap Net Income Loss
NetIncomeLoss
-18644000
us-gaap Net Income Loss
NetIncomeLoss
-13307000
CY2021Q3 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
162721000
CY2021Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.06
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.12
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.10
CY2021Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
8551000
CY2020Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
21430000
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
8551000
CY2020Q3 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
138857000
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
153998000
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
138774000
CY2020Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.03
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
21430000

Files In Submission

Name View Source Status
0001558370-21-014427-index-headers.html Edgar Link pending
0001558370-21-014427-index.html Edgar Link pending
0001558370-21-014427.txt Edgar Link pending
0001558370-21-014427-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
xxii-20210930.xsd Edgar Link pending
xxii-20210930x10q.htm Edgar Link pending
xxii-20210930x10q_htm.xml Edgar Link completed
xxii-20210930xex31d1.htm Edgar Link pending
xxii-20210930xex31d2.htm Edgar Link pending
xxii-20210930xex32d1.htm Edgar Link pending
xxii-20210930_cal.xml Edgar Link unprocessable
xxii-20210930_def.xml Edgar Link unprocessable
xxii-20210930_lab.xml Edgar Link unprocessable
xxii-20210930_pre.xml Edgar Link unprocessable